443914-95-2 Usage
Uses
Used in Scientific Research:
2-Bromo-1-(5-fluoro-2-methoxy-phenyl)-ethanone is used as a research compound for its distinctive chemical structure, which may contribute to the development of new materials or pharmaceuticals. Its properties are currently being explored in laboratory settings to determine its potential applications and benefits.
Used in Material Production:
In the field of material science, 2-Bromo-1-(5-fluoro-2-methoxy-phenyl)-ethanone is used as a precursor or intermediate in the synthesis of advanced materials. Its unique structure may enable the creation of novel compounds with specific properties, such as improved chemical stability or enhanced reactivity.
Used in Pharmaceutical Development:
2-Bromo-1-(5-fluoro-2-methoxy-phenyl)-ethanone is used as a key component in the development of new pharmaceuticals. Its chemical properties may offer potential therapeutic benefits, and ongoing research is focused on identifying its potential uses in the treatment of various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 443914-95-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,3,9,1 and 4 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 443914-95:
(8*4)+(7*4)+(6*3)+(5*9)+(4*1)+(3*4)+(2*9)+(1*5)=162
162 % 10 = 2
So 443914-95-2 is a valid CAS Registry Number.
443914-95-2Relevant academic research and scientific papers
3-O-Substituted benzyl pyridazinone derivatives as COX inhibitors
Chintakunta, Vamsee Krishna,Akella, Venkateswarlu,Vedula, Manohar Sharma,Mamnoor, Prem Kumar,Mishra, Parimal,Casturi, Seshagiri Rao,Vangoori, Akhila,Rajagopalan, Ramanujam
, p. 339 - 347 (2007/10/03)
New 3-O-substituted benzyl pyridazinone compounds have been synthesised and evaluated for their cyclooxygenase inhibitory activity and COX-2 selectivity. Among the compounds synthesised, three compounds (11b-11d) have shown in vitro COX-2 selectivity. These compounds have been evaluated for their in vivo potential using carrageenan-induced rat paw edema assay. One compound (11b) showed 32% anti-inflammatory activity at 30 mg kg-1 dose.
Diaminothiazoles having antiproliferative activity
-
, (2008/06/13)
Disclosed are novel diaminothiazoles that are selective inhibitors of Cdk4. These compounds and their pharmaceutically acceptable salts and esters are anti-proliferative agents useful in the treatment or control of solid tumors, in particular breast, colon, lung and prostate tumors. Also disclosed are pharmaceutical compositions containing these compounds as well as intermediates useful in the preparation of the compounds.
